WATSON 240 0.5 (Lorazepam 0.5 mg)

Pill with imprint WATSON 240 0.5 is White, Round and has been identified as Lorazepam 0.5 mg. It is supplied by Watson Laboratories, Inc..

Lorazepam is used in the treatment of anxiety; insomnia; icu agitation; light anesthesia; nausea/vomiting and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 240 0.5

Lorazepam

Imprint:

WATSON 240 0.5

Strength:

0.5 mg

Color:

White

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Benzodiazepine anticonvulsants
Benzodiazepines
Miscellaneous antiemetics

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

4 - Some potential for abuse

Labeler / Supplier:

Watson Laboratories, Inc.

Inactive Ingredients:

• lactose
• magnesium stearate
• microcrystalline cellulose
• polacrilin potassium

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00591-0240	Watson Pharmaceuticals, Inc.
63739-0499	McKesson Packaging Services
66267-0133	Nucare Pharmaceuticals Inc. (repackager)
43063-0057	PDRX Pharmaceuticals Inc. (repackager)
55289-0402	PDRX Pharmaceuticals Inc. (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer